Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1048395/full |
| _version_ | 1797996781291700224 |
|---|---|
| author | Andreas Heinzel Eva Schrezenmeier Florina Regele Karin Hu Lukas Raab Michael Eder Christof Aigner Rhea Jabbour Constantin Aschauer Ana-Luisa Stefanski Thomas Dörner Klemens Budde Roman Reindl-Schwaighofer Rainer Oberbauer |
| author_facet | Andreas Heinzel Eva Schrezenmeier Florina Regele Karin Hu Lukas Raab Michael Eder Christof Aigner Rhea Jabbour Constantin Aschauer Ana-Luisa Stefanski Thomas Dörner Klemens Budde Roman Reindl-Schwaighofer Rainer Oberbauer |
| author_sort | Andreas Heinzel |
| collection | DOAJ |
| first_indexed | 2024-04-11T10:22:53Z |
| format | Article |
| id | doaj.art-91da98b5636a45be96c1d5d258eb34b0 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-11T10:22:53Z |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-91da98b5636a45be96c1d5d258eb34b02022-12-22T04:29:41ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-10-01910.3389/fmed.2022.10483951048395Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trialAndreas Heinzel0Eva Schrezenmeier1Florina Regele2Karin Hu3Lukas Raab4Michael Eder5Christof Aigner6Rhea Jabbour7Constantin Aschauer8Ana-Luisa Stefanski9Thomas Dörner10Klemens Budde11Roman Reindl-Schwaighofer12Rainer Oberbauer13Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDepartment of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, AustriaDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austriahttps://www.frontiersin.org/articles/10.3389/fmed.2022.1048395/fullCOVID-19kidney transplantationCOVID-19 vaccinationheterologous vaccinationthird vaccination |
| spellingShingle | Andreas Heinzel Eva Schrezenmeier Florina Regele Karin Hu Lukas Raab Michael Eder Christof Aigner Rhea Jabbour Constantin Aschauer Ana-Luisa Stefanski Thomas Dörner Klemens Budde Roman Reindl-Schwaighofer Rainer Oberbauer Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial Frontiers in Medicine COVID-19 kidney transplantation COVID-19 vaccination heterologous vaccination third vaccination |
| title | Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial |
| title_full | Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial |
| title_fullStr | Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial |
| title_full_unstemmed | Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial |
| title_short | Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial |
| title_sort | corrigendum three month follow up of heterologous vs homologous third sars cov 2 vaccination in kidney transplant recipients secondary analysis of a randomized controlled trial |
| topic | COVID-19 kidney transplantation COVID-19 vaccination heterologous vaccination third vaccination |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.1048395/full |
| work_keys_str_mv | AT andreasheinzel corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT evaschrezenmeier corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT florinaregele corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT karinhu corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT lukasraab corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT michaeleder corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT christofaigner corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT rheajabbour corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT constantinaschauer corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT analuisastefanski corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT thomasdorner corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT klemensbudde corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT romanreindlschwaighofer corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial AT raineroberbauer corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial |